Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Sulfonamides derived from tricyclyl-2-aminocycloalkanols as anticancer agents

Sulfonamides derived from tricyclyl-2-aminocycloalkanols as anticancer agents

US Patent 9937186 · Granted Apr 10, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

3-diarylmethylenes and uses thereof2025
Dihydropyridines for the treatment of cognitive impairment or traumatic brain in2025
Dihydropyridines for the treatment of cognitive impairment or traumatic brain in2022
Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents2020
Compositions and methods for treating cancer2020
Stereospecific process for 3-heterocyclylcycloaliphatic-1,2-diols2019
Stereospecific process for 3-heterocyclylcycloaliphatic-1,2-diols2019
Cyclic vinylogous amides as bromodomain inhibitors2019
Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents2019
Constrained tricyclic sulfonamides2018
Constrained tricyclic sulfonamides2018
Cyclic vinylogous amides as bromodomain inhibitors2018